CWSR
IMMU

Chessman Wealth Strategies RIA’s Immunomedics Inc IMMU Stock Holding History

Chessman Wealth Strategies RIA’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed -$2K – 191
2018
Q3 		$2K Buy
+100
New +$2.37K ﹤0.01% 179

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Chessman Wealth Strategies RIA's IMMU Position: Q4 2018 in Review

Chessman Wealth Strategies RIA sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 100 shares — an estimated $2K sold.

Chessman Wealth Strategies RIA first reported a position in IMMU in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • Chessman Wealth Strategies RIA reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
  • Chessman Wealth Strategies RIA sold 100 Immunomedics Inc shares in Q4 2018, an estimated $2K.
  • Chessman Wealth Strategies RIA first reported a position in Immunomedics Inc in Q3 2018 and held it in 1 quarter.
  • Chessman Wealth Strategies RIA's Immunomedics Inc position peaked at $2K in Q3 2018.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on Chessman Wealth Strategies RIA's 13F filing for Q4 2018, filed 14 Jan 2019.